Planar Imaging of 99mTc-labeled (bis(N-ethoxy, N-ethyl Dithiocarbamato) Nitrido Technetium[V]) Can Detect Resting Ischemia

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 1997 May 1

PMID 9199259

Citations 6

Authors

G Johnson 3rd

K N Nguyen

Z Liu

P Gao

R Pasqualini

R D Okada

Affiliations

Soon will be listed here.

Abstract

Background: (99m)Tc-labeled (bis(N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium(V)) ([99m]TcN-NOET) is a new lipophilic, neutral-charge cardiac perfusion imaging agent that demonstrates apparent redistribution in animal models and humans. The purpose of this study was to determine whether the kinetics of (99m)TcN-NOET are suitable for the detection of resting ischemia.

Methods And Results: Microspheres were injected at baseline and simultaneously with (99m)TcN-NOET after a 90% reduction in resting flow in the left circumflex coronary artery in six open-chest canine experiments. The relationship of flow and activity early after injection was determined in one experiment by termination at 10 minutes. The flow ratio (left circumflex/left anterior descending coronary artery) after stenosis fell significantly (0.87 +/- 0.04 vs 0.46 +/- 0.04; p < 0.05). The end-tissue (99m)Tc ratio (0.78 +/- 0.05) was significantly higher than the flow ratio at injection (0.46 +/- 0.04; p < 0.05), indicating substantial redistribution. In vivo imaging was conducted during 2 hours in five experiments, followed by ex vivo imaging. Myocardial clearance from 10 minutes onward was biphasic in left anterior descending and monophasic in left circumflex coronary arteries. Myocardial clearance from 10 to 60 minutes was delayed in left circumflex (35.5% +/- 8.1%) versus left anterior descending coronary arteries (49.2% +/- 8.6%; p < 0.05). No significant difference was observed from 60- to 120-minute clearance. Five of five experiments demonstrated initial defects and complete fill-in at 90 to 120 minutes by qualitative assessment. Quantitation of ex vivo images confirmed significant redistribution.

Conclusions: Resting ischemia caused by moderate to severe stenosis can be detected on scans with (99m)TcN-NOET. Redistribution was near complete in this model by 90 to 120 minutes. (99m)TcN-NOET is a promising new agent for the detection of coronary artery disease in viable myocardium and warrants further investigation.

Citing Articles

A brief overview of metal complexes as nuclear imaging agents.

MacPherson D, Fung K, Cook B, Francesconi L, Zeglis B Dalton Trans. 2019; 48(39):14547-14565.

PMID: 31556418 PMC: 6829947. DOI: 10.1039/c9dt03039e.

(99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.

Johnson 3rd G, Okada C, Hocherman S, Liu Z, Hart C, Khaw B Eur J Nucl Med Mol Imaging. 2005; 33(3):319-28.

PMID: 16237571 DOI: 10.1007/s00259-005-1913-x.

Technetium 99m-N-NOET: although not equivalent to thallium-201, it still offers new opportunities.

Sinusas A J Nucl Cardiol. 2000; 7(2):185-8.

PMID: 10796010 DOI: 10.1016/s1071-3581(00)90043-6.

Optimal timing for initial and redistribution technetium 99m-N-NOET image acquisition.

Petruzella F, Ruiz M, Katsiyiannis P, WATSON D, Pasqualini R, Beller G J Nucl Cardiol. 2000; 7(2):123-31.

PMID: 10796001 DOI: 10.1016/s1071-3581(00)90032-1.

The effect of ischemic injury on the cardiac transport of Tc-99m N-NOET in the isolated rabbit heart.

Holly T, Leppo J, Gilmore M, Reinhardt C, Dahlberg S J Nucl Cardiol. 1999; 6(6):633-40.

PMID: 10608591 DOI: 10.1016/s1071-3581(99)90101-0.

References

Johnson 3rd G, Glover D, Hebert C, Okada R . Early myocardial clearance kinetics of technetium-99m-teboroxime differentiate normal and flow-restricted canine myocardium at rest. J Nucl Med. 1993; 34(4):630-6. View

RUMSEY W, Rosenspire K, Nunn A . Myocardial extraction of teboroxime: effects of teboroxime interaction with blood. J Nucl Med. 1992; 33(1):94-101. View

Stewart R, Schwaiger M, Hutchins G, Chiao P, Gallagher K, Nguyen N . Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. J Nucl Med. 1990; 31(7):1183-90. View

Pohost G, Okada R, OKeefe D, GEWIRTZ H, Beller G, Strauss H . Thallium redistribution in dogs with severe coronary artery stenosis of fixed caliber. Circ Res. 1981; 48(3):439-46. DOI: 10.1161/01.res.48.3.439. View

Heller L, Villegas B, Reinhardt C, Dahlberg S, Marcel R, Leppo J . Teboroxime is a marker of reperfusion after myocardial infarction. J Nucl Cardiol. 1996; 3(1):2-8. DOI: 10.1016/s1071-3581(96)90018-5. View

Uccelli L, Giganti M, Duatti A, Bolzati C, Pasqualini R, Cittanti C . Subcellular distribution of technetium-99m-N-NOEt in rat myocardium. J Nucl Med. 1995; 36(11):2075-9. View

Johnson 3rd G, Glover D, Hebert C, Okada R . Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole: differentiation of stenosis severity in canine myocardium. J Nucl Med. 1995; 36(1):111-9. View

Dahlberg S, Gilmore M, Leppo J . Interaction of technetium 99m-labeled teboroxime with red blood cells reduces the compound's extraction and increases apparent cardiac washout. J Nucl Cardiol. 1994; 1(3):270-9. DOI: 10.1007/BF02940341. View

Fagret D, Marie P, Brunotte F, Giganti M, Le Guludec D, Bertrand A . Myocardial perfusion imaging with technetium-99m-Tc NOET: comparison with thallium-201 and coronary angiography. J Nucl Med. 1995; 36(6):936-43. View

10.

Stewart R, Heyl B, ORourke R, Blumhardt R, Miller D . Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med. 1991; 32(10):2000-8. View

11.

Domenech R, Hoffman J, NOBLE M, Saunders K, Henson J, Subijanto S . Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circ Res. 1969; 25(5):581-96. DOI: 10.1161/01.res.25.5.581. View

12.

Johnson 3rd G, Nguyen K, Pasqualini R, Okada R . Interaction of technetium-99m-N-NOET with blood elements: potential mechanism of myocardial redistribution. J Nucl Med. 1997; 38(1):138-43. View

13.

Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V, Hoffschir D . Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med. 1994; 35(2):334-41. View

14.

Johnson 3rd G, Allton I, Nguyen K, Lauinger J, Beju D, Pasqualini R . Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium. J Nucl Cardiol. 1996; 3(1):42-54. DOI: 10.1016/s1071-3581(96)90023-9. View

15.

Rosenspire K, RUMSEY W, Jurisson S, Hirth W, Narra R . [99mTc] Teboroxime and [99mTc]Cl(DMG)3B2MP: binding characteristics andmetabolism of two [99mTc]BATOs in blood and tissues. Nucl Med Biol. 1993; 20(4):395-400. DOI: 10.1016/0969-8051(93)90069-7. View

16.

Gray W, GEWIRTZ H . Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis. Circulation. 1991; 84(4):1796-807. DOI: 10.1161/01.cir.84.4.1796. View

17.

Yipintsoi T, Dobbs Jr W, Scanlon P, Knopp T, Bassingthwaighte J . Regional distribution of diffusible tracers and carbonized microspheres in the left ventricle of isolated dog hearts. Circ Res. 1973; 33(5):573-87. PMC: 3008666. DOI: 10.1161/01.res.33.5.573. View

18.

Johnson 3rd G, Glover D, Hebert C, Okada R . Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole. J Nucl Cardiol. 1994; 1(4):338-50. DOI: 10.1007/BF02939955. View

19.

Okada R, Jacobs M, Daggett W, Leppo J, Strauss H, Newell J . Thallium-201 kinetics in nonischemic canine myocardium. Circulation. 1982; 65(1):70-7. DOI: 10.1161/01.cir.65.1.70. View

20.

Ghezzi C, Fagret D, Arvieux C, MATHIEU J, Bontron R, Pasqualini R . Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med. 1995; 36(6):1069-77. View